ZANGHI', AURORA
 Distribuzione geografica
Continente #
NA - Nord America 308
EU - Europa 207
AS - Asia 43
AF - Africa 24
SA - Sud America 1
Totale 583
Nazione #
US - Stati Uniti d'America 303
IE - Irlanda 74
IT - Italia 57
CN - Cina 29
SN - Senegal 24
DE - Germania 22
RU - Federazione Russa 19
UA - Ucraina 13
VN - Vietnam 9
CA - Canada 5
GB - Regno Unito 5
NL - Olanda 4
FR - Francia 3
IN - India 2
SE - Svezia 2
AT - Austria 1
BE - Belgio 1
BG - Bulgaria 1
CH - Svizzera 1
EC - Ecuador 1
HK - Hong Kong 1
HR - Croazia 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
PL - Polonia 1
TR - Turchia 1
Totale 583
Città #
Chandler 133
Dublin 74
Houston 31
Catania 24
Dakar 24
Andover 19
Bremen 19
Cambridge 19
Lawrence 19
Des Moines 13
Jacksonville 9
Nanjing 7
Beijing 6
Wilmington 6
Boardman 5
Dong Ket 5
Hanoi 4
Nanchang 4
Padova 4
Den Haag 3
Hebei 3
Saint Petersburg 3
Toronto 3
Ashburn 2
Kunming 2
Lanuvio 2
London 2
Moscow 2
Ottawa 2
San Francisco 2
Tianjin 2
Acireale 1
Amsterdam 1
Ann Arbor 1
Belpasso 1
Brussels 1
Central 1
Changsha 1
Fiumicino 1
Foggia 1
Frankfurt Am Main 1
Guangzhou 1
Jiaxing 1
Livorno 1
Luxembourg 1
Mascalucia 1
New Delhi 1
New York 1
Palermo 1
Providence 1
Quito 1
Rome 1
San Mateo 1
Sant'Ilario d'Enza 1
Scaletta Zanclea 1
Shenyang 1
Sofia 1
Vilnius 1
Zagreb 1
Zogno 1
Totale 482
Nome #
Management of dysphagia in multiple sclerosis: current best practice 69
Can new chemical therapies improve the management of multiple sclerosis in children? 47
Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience 46
Lateral switch to IFN beta-1a 44 mcg may be effective as escalation switch to fingolimod in selected persons with relapsing remitting multiple sclerosis: a real-world setting experience 40
Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort 40
Are oligoclonal bands associated to lower retinal layer thickness at the time of relapsing remitting multiple sclerosis diagnosis? Evidence from an exploratory study 37
Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experience 36
Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study 33
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience 33
An update on the safety of treating relapsing-remitting multiple sclerosis 32
The Neutrophil-to-Lymphocyte Ratio is Related to Disease Activity in Relapsing Remitting Multiple Sclerosis 28
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 27
Pharmacoeconomics of synthetic therapies for multiple sclerosis 26
Placing CD20-targeted B cell depletion in multiple sclerosis therapeutic scenario: Present and future perspectives 25
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 25
Pharmacotherapeutic management of lower urinary tract symptoms in Multiple Sclerosis Patients 24
Gonadal Steroids and Sperm Quality in a Cohort of Relapsing Remitting Multiple Sclerosis: A Case-Control Study 22
Immunosuppression in relapsing remitting multiple sclerosis: moving towards personalized treatment 21
Mental health status of relapsing-remitting multiple sclerosis Italian patients returning to work soon after the easing of lockdown during COVID-19 pandemic: A monocentric experience 19
Totale 630
Categoria #
all - tutte 1361
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1361


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20182 0000 00 00 1010
2018/201938 0240 04 25 6294
2019/202083 324164 43 22 4147
2020/202152 1523 201 20 3915
2021/2022126 32342 201 195 30343
2022/2023327 22201053 3254 166 69000
Totale 630